Molina Healthcare, Inc.
HealthcareNYSE:MOH · New York Stock Exchange
+$6.75 today
Vol 1.18M · Avg 1.40M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
11.6%
avg 18.1%
ROIC
7.6%
avg 12.0%
ROA
3.0%
avg 4.9%
Analysis
ROE is currently the strongest return metric at 11.6% versus its period average of 18.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Joseph Michael Zubretsky | President, Chief Executive Officer & Director | $2.14M | — | 69 | $99,015.00 | 0.19% |
Mark Lowell Keim | Senior EVice President, Chief Financial Officer & Treasurer | $1.31M | — | 61 | $83,251.00 | 0.16% |
James Edwin Woys | Senior EVP & COO | $856,409.00 | — | 67 | $73,018.00 | 0.14% |
Maurice Sebastian Hebert | Chief Accounting Officer | $835,696.00 | — | 63 | $12,815.00 | 0.02% |
Jeffrey Don Barlow | Chief Legal Officer & Corporate Secretary | $736,037.00 | — | 63 | $67,175.00 | 0.13% |
Debra Jean Bacon | Executive Vice President of Medicaid | $723,031.00 | — | 59 | $12,190.00 | 0.02% |
Larry D. Anderson | Executive Vice President & Chief Human Resources Officer | — | — | — | $67,175.00 | 0.13% |
Joann Zarza-Garrido | Vice President of Compliance | — | — | — | — | — |
Keith Wilson | Chief Medical Officer | — | — | — | $29,441.00 | 0.06% |
Jeffrey Geyer | Head of Investor Relations | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
3
$1.66M
Sells
5
$3.66M
Net Sentiment
$2.00M
Net selling
Most Active
ROMNEY RONNA
2 transactions
Analysis
Insiders reported 3 buys worth $1.66M and 5 sells worth $3.66M over the last 12 months. That adds up to net selling of $2.00M. ROMNEY RONNA was the most active insider with 2 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +130.7% | +15.3% (15yr)1 analysts |
| Revenue | N/A | N/A | +32.7% | +9.2% (15yr)5 analysts |
| Net Income | N/A | N/A | +144.4% | +14.6% (15yr)5 analysts |
| EBIT | N/A | N/A | +111.2% | +11.1% (15yr)5 analysts |
Analysis
Recent growth has been strongest in Net Income at +144.4% over three years. Forward estimates point to EPS at +15.3% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
DaVita Inc.
NYSE:DVA
$13.48B
Globus Medical, Inc.
NYSE:GMED
$10.89B
Masimo Corporation
NASDAQ:MASI
$9.42B
Henry Schein, Inc.
NASDAQ:HSIC
$9.31B
Halozyme Therapeutics, Inc.
NASDAQ:HALO
$8.26B
Bio-Rad Laboratories, Inc.
NYSE:BIO
$7.72B
AptarGroup, Inc.
NYSE:ATR
$7.53B
HealthEquity, Inc.
NASDAQ:HQY
$7.38B
Avantor, Inc.
NYSE:AVTR
$6.54B
Grifols, S.A.
NASDAQ:GRFS
$6.50B
Who manages MOH?
Molina Healthcare, Inc. (MOH) lists 10 active executives. The top listed executive is Jeffrey Don Barlow, Chief Legal Officer & Corporate Secretary.
Are MOH insiders buying or selling?
Recent insider activity shows net buying of $20.88M.
Explore More
Continue the stock analysis
Jump to another research area for this company.